Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
18 hedge funds and large institutions have $41.8M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more funds holding
Funds holding: 16 → 18 (+2)
0.72% more ownership
Funds ownership: 1.68% → 2.4% (+0.72%)
Holders
18
Holding in Top 10
–
Calls
$22.6M
Puts
$6.7M
Top Buyers
| 1 | +$9.03M | |
| 2 | +$4.09M | |
| 3 | +$3.13M | |
| 4 |
Jane Street
New York
|
+$3.11M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$1.41M |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$752K | |
| 3 | -$373K | |
| 4 |
QT
Quantbot Technologies
New York
|
-$177K |
| 5 |
Citigroup
New York
|
-$19.5K |